Interstitial Lung Disease in a Patient Treated with Denosumab

Denosumab is an antiresorptive agent widely used for treating osteoporosis. Atypical femur fractures, osteonecrosis of the jaw and hypocalcaemia are well-known possible adverse effects of this drug. We present, to our knowledge, the first case report in the English literature of clinically significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Ana Campo, Carrascosa, Miguel F, Concha, Sergio Tapia, Gil, Aníbal Hernández, Rivero, Juan García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663050/
https://www.ncbi.nlm.nih.gov/pubmed/31410352
http://dx.doi.org/10.12890/2019_001131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663050/
https://www.ncbi.nlm.nih.gov/pubmed/31410352
http://dx.doi.org/10.12890/2019_001131

Ejemplares similares